MTHFD2-mediated redox homeostasis promotes gastric cancer progression under hypoxic conditions

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–249.
   PubMed Web of Science ®Google Scholar
• Ju HQ, Lin JF, Tian T, et al. NADPH homeostasis in cancer: functions, mechanisms and therapeutic implications. Signal Transd Target Ther. 2020;5:231.
   PubMed Web of Science ®Google Scholar
• Lu YX, Ju HQ, Liu ZX, et al. ME1 regulates NADPH homeostasis to promote gastric cancer growth and metastasis. Cancer Res. 2018;78:1972–1985.
   PubMed Web of Science ®Google Scholar
• Li S, Zhuang Z, Wu T, et al. Nicotinamide nucleotide transhydrogenase-mediated redox homeostasis promotes tumor growth and metastasis in gastric cancer. Redox Biol. 2018;18:246–255.
   PubMed Web of Science ®Google Scholar
• Gorrini C, Harris IS, Mak TW. Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discov. 2013;12:931–947.
   PubMed Web of Science ®Google Scholar
• Cheung EC, Vousden KH. The role of ROS in tumour development and progression. Nat Rev Cancer. 2022;22:280–297.
   PubMed Web of Science ®Google Scholar
• Hayes JD, Dinkova-Kostova AT, Tew KD. Oxidative stress in cancer. Cancer Cell. 2020;38:167–197.
   PubMed Web of Science ®Google Scholar
• Chen L, Zhang Z, Hoshino A, et al. NADPH production by the oxidative pentose-phosphate pathway supports folate metabolism. Nat Metab. 2019;1:404–415.
   PubMedGoogle Scholar
• Chen C, Lai X, Zhang Y, et al. NADPH metabolism determines the leukemogenic capacity and drug resistance of AML cells. Cell Rep. 2022;39:110607.
   PubMed Web of Science ®Google Scholar
• Niu X, Stancliffe E, Gelman SJ, et al. Cytosolic and mitochondrial NADPH fluxes are independently regulated. Nat Chem Biol. 2023;19:837–845.
   PubMed Web of Science ®Google Scholar
• Yang C, Zhang J, Liao M, et al. Folate-mediated one-carbon metabolism: a targeting strategy in cancer therapy. Drug Discov Today. 2021;26:817–825.
   PubMed Web of Science ®Google Scholar
• Ducker GS, Rabinowitz JD. One-carbon metabolism in health and disease. Cell Metab. 2017;25:27–42.
   PubMed Web of Science ®Google Scholar
• Yu H, Wang H, Xu HR, et al. Overexpression of MTHFD1 in hepatocellular carcinoma predicts poorer survival and recurrence. Future Oncol. 2019;15:1771–1780.
   PubMed Web of Science ®Google Scholar
• Meng Q, Lu YX, Wei C, et al. Arginine methylation of MTHFD1 by PRMT5 enhances anoikis resistance and cancer metastasis. Oncogene. 2022;41:3912–3924.
   PubMed Web of Science ®Google Scholar
• Shi Y, Xu Y, Yao J, et al. MTHFD2 promotes tumorigenesis and metastasis in lung adenocarcinoma by regulating AKT/GSK-3β/β-catenin signalling. J Cell Mol Med. 2021;25:7013–7027.
   PubMed Web of Science ®Google Scholar
• Ju HQ, Lu YX, Chen DL, et al. Modulation of redox homeostasis by inhibition of MTHFD2 in colorectal cancer, mechanisms and therapeutic implications. J Natl Cancer Inst. 2019;111:584–596.
   PubMedGoogle Scholar
• Green NH, Galvan DL, Badal SS, et al. MTHFD2 links RNA methylation to metabolic reprogramming in renal cell carcinoma. Oncogene. 2019;38:6211–6225.
   PubMed Web of Science ®Google Scholar
• Huang J, Qin Y, Lin C, et al. MTHFD2 facilitates breast cancer cell proliferation via the AKT signaling pathway. Exp Ther Med. 2021;22:703.
   PubMed Web of Science ®Google Scholar
• Han Y, Chen P, Zhang Y, et al. Synergy between auranofin and celecoxib against colon cancer in vitro and in vivo through a novel redox-mediated mechanism. Cancers. 2019;11:931.
   Web of Science ®Google Scholar
• Liu J, Liu ZX, Wu QN, et al. Long noncoding RNA AGPG regulates PFKFB3-mediated tumor glycolytic reprogramming. Nat Commun. 2020;11:1507.
   PubMed Web of Science ®Google Scholar
• Tong Y, Guo D, Lin SH, et al. SUCLA2-coupled regulation of GLS succinylation and activity counteracts oxidative stress in tumor cells. Mol Cell. 2021;81:2303–2316.
   PubMed Web of Science ®Google Scholar
• Zhao R, Feng T, Gao L, et al. PPFIA4 promotes castration-resistant prostate cancer by enhancing mitochondrial metabolism through MTHFD2. J Exp Clin Cancer Res. 2022;41:125.
   PubMed Web of Science ®Google Scholar
• Kawai J, Toki T, Ota M, et al. Discovery of a potent, selective, and orally available MTHFD2 inhibitor (DS18561882) with in vivo antitumor activity. J Med Chem. 2019;62:10204–10220.
   PubMedGoogle Scholar
• Wang Y, Lu JH, Wang F, et al. Inhibition of fatty acid catabolism augments the efficacy of oxaliplatin-based chemotherapy in gastrointestinal cancers. Cancer Lett. 2020;473:74–89.
   PubMed Web of Science ®Google Scholar
• Guzy RD, Hoyos B, Robin E, et al. Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab. 2005;1:401–408.
   PubMed Web of Science ®Google Scholar
• Smith KA, Waypa GB, Schumacker PT. Redox signaling during hypoxia in mammalian cells. Redox Biol. 2017;13:228–234.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–674.
   PubMed Web of Science ®Google Scholar
• Pavlova NN, Zhu J, Thompson CB. The hallmarks of cancer metabolism: still emerging. Cell Metab. 2022;34:355–377.
   PubMed Web of Science ®Google Scholar
• Harris IS, DeNicola GM. The complex interplay between antioxidants and ROS in cancer. Trends Cell Biol. 2020;30:440–451.
   PubMed Web of Science ®Google Scholar
• Boese AC, Kang S. Mitochondrial metabolism-mediated redox regulation in cancer progression. Redox Biol. 2021;42:101870.
   PubMed Web of Science ®Google Scholar
• Klaunig JE. Oxidative stress and cancer. Curr Pharm Des. 2018;24:4771–4778.
   PubMed Web of Science ®Google Scholar
• Liu J, Xia X, Huang P. xCT: a critical molecule that links cancer metabolism to redox signaling. Mol Ther. 2020;28:2358–2366.
   PubMed Web of Science ®Google Scholar
• Zhao LN, Björklund M, Caldez MJ, et al. Therapeutic targeting of the mitochondrial one-carbon pathway: perspectives, pitfalls, and potential. Oncogene. 2021;40:2339–2354.
   PubMed Web of Science ®Google Scholar
• Ghergurovich JM, Xu X, Wang JZ, et al. Methionine synthase supports tumour tetrahydrofolate pools. Nat Metab. 2021;3:1512–1520.
   PubMedGoogle Scholar
• Shang M, Yang H, Yang R, et al. The folate cycle enzyme MTHFD2 induces cancer immune evasion through PD-L1 up-regulation. Nat Commun. 2021;12:1940.
   PubMed Web of Science ®Google Scholar
• Zhang Z, TeSlaa T, Xu X, et al. Serine catabolism generates liver NADPH and supports hepatic lipogenesis. Nat Metab. 2021;3:1608–1620.
   PubMedGoogle Scholar
• Sdelci S, Rendeiro AF, Rathert P, et al. MTHFD1 interaction with BRD4 links folate metabolism to transcriptional regulation. Nat Genet. 2019;51:990–998.
   PubMed Web of Science ®Google Scholar
• Pikman Y, Puissant A, Alexe G, et al. Targeting MTHFD2 in acute myeloid leukemia. J Exp Med. 2016;213:1285–1306.
   PubMed Web of Science ®Google Scholar
• Zhu Z, Leung GKK. More than a metabolic enzyme: MTHFD2 as a novel target for anticancer therapy? Front Oncol. 2020;10:658.
   PubMed Web of Science ®Google Scholar
• Li G, Wu J, Li L, et al. p53 deficiency induces MTHFD2 transcription to promote cell proliferation and restrain DNA damage. Proc Natl Acad Sci USA. 2021;118(28):e2019822118.
   Web of Science ®Google Scholar
• Yang M, Vousden KH. Serine and one-carbon metabolism in cancer. Nat Rev Cancer. 2016;16:650–662.
   PubMed Web of Science ®Google Scholar
• Qiao S, Lu W, Glorieux C, et al. Wild-type IDH2 protects nuclear DNA from oxidative damage and is a potential therapeutic target in colorectal cancer. Oncogene. 2021;40:5880–5892.
   PubMed Web of Science ®Google Scholar
• Li S, Wu T, Lu YX, et al. Obesity promotes gastric cancer metastasis via diacylglycerol acyltransferase 2-dependent lipid droplets accumulation and redox homeostasis. Redox Biol. 2020;36:101596.
   PubMed Web of Science ®Google Scholar
• Han Y, Zhang YY, Pan YQ, et al. IL-1β-associated NNT acetylation orchestrates iron-sulfur cluster maintenance and cancer immunotherapy resistance. Mol Cell. 2023;83:1887–1902.
   PubMed Web of Science ®Google Scholar
• Christensen KE, Mirza IA, Berghuis AM, et al. Magnesium and phosphate ions enable NAD binding to methylenetetrahydrofolate dehydrogenase-methenyltetrahydrofolate cyclohydrolase. J Biol Chem. 2005;280:34316–34323.
   PubMed Web of Science ®Google Scholar
• Rakotomalala A, Escande A, Furlan A, et al. Hypoxia in solid tumors: how low oxygenation impacts the “Six Rs” of radiotherapy. Front Endocrinol. 2021;12:742215.
   PubMed Web of Science ®Google Scholar
• Jing X, Yang F, Shao C, et al. Role of hypoxia in cancer therapy by regulating the tumor microenvironment. Mol Cancer. 2019;18:157.
   PubMed Web of Science ®Google Scholar
• Kopecka J, Salaroglio IC, Perez-Ruiz E, et al. Hypoxia as a driver of resistance to immunotherapy, drug resistance updates: reviews and commentaries in antimicrobial and anticancer chemotherapy. Drug Resist Update. 2021;59:100787.
   PubMedGoogle Scholar
• Yuen VW, Wong CC. Hypoxia-inducible factors and innate immunity in liver cancer. J Clin Invest. 2020;130:5052–5062.
   PubMed Web of Science ®Google Scholar
• Wicks EE, Semenza GL. Hypoxia-inducible factors: cancer progression and clinical translation. J Clin Invest. 2022;132(11):e159839.
   Web of Science ®Google Scholar
• Mennerich D, Kubaichuk K, Kietzmann T. DUBs, hypoxia, and cancer. Trends Cancer. 2019;5:632–653.
   PubMed Web of Science ®Google Scholar
• Gilkes DM, Semenza GL, Wirtz D. Hypoxia and the extracellular matrix: drivers of tumour metastasis. Nat Rev Cancer. 2014;14:430–439.
   PubMed Web of Science ®Google Scholar
• Musatov A, Robinson NC. Susceptibility of mitochondrial electron-transport complexes to oxidative damage. Focus on cytochrome c oxidase. Free Radical Res. 2012;46:1313–1326.
   PubMed Web of Science ®Google Scholar
• Santini SJ, Cordone V, Falone S, et al. Role of mitochondria in the oxidative stress induced by electromagnetic fields: focus on reproductive systems. Oxid Med Cell Longevity. 2018;2018:5076271.
   PubMed Web of Science ®Google Scholar
• Zhang B, Zheng R, Liu Y, et al. Perylene-mediated electron leakage in respiratory chain to trigger endogenous ROS burst for hypoxic cancer chemo-immunotherapy. Adv Sci. 2023;10:e2204498.
   Web of Science ®Google Scholar